Home/Filings/3/0000899243-20-015994
3//SEC Filing

Green Park & Golf Ventures II, LLC 3

Accession 0000899243-20-015994

CIK 0001763950other

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 6:50 PM ET

Size

26.5 KB

Accession

0000899243-20-015994

Insider Transaction Report

Form 3
Period: 2020-06-10
Holdings
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (292,605 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (23,733 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (131,697 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (41,535 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (15,804 underlying)
  • Common Stock, par value $0.0001

    (indirect: See Footnote)
    169,756
Holdings
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (23,733 underlying)
  • Common Stock, par value $0.0001

    (indirect: See Footnote)
    169,756
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (292,605 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (131,697 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (15,804 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (41,535 underlying)
Holdings
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (131,697 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (292,605 underlying)
  • Common Stock, par value $0.0001

    (indirect: See Footnote)
    169,756
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (15,804 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (41,535 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (23,733 underlying)
Holdings
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (131,697 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (23,733 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (41,535 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (292,605 underlying)
  • Common Stock, par value $0.0001

    (indirect: See Footnote)
    169,756
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (15,804 underlying)
Holdings
  • Common Stock, par value $0.0001

    (indirect: See Footnote)
    169,756
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (41,535 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (292,605 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (131,697 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (23,733 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (15,804 underlying)
Holdings
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (131,697 underlying)
  • Common Stock, par value $0.0001

    (indirect: See Footnote)
    169,756
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (41,535 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (292,605 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (23,733 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (15,804 underlying)
Holdings
  • Common Stock, par value $0.0001

    (indirect: See Footnote)
    169,756
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (41,535 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (292,605 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (131,697 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (23,733 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (15,804 underlying)
Holdings
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (41,535 underlying)
  • Common Stock, par value $0.0001

    (indirect: See Footnote)
    169,756
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (292,605 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (131,697 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (23,733 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (15,804 underlying)
Holdings
  • Common Stock, par value $0.0001

    (indirect: See Footnote)
    169,756
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (41,535 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (292,605 underlying)
  • Series A Preferred Stock, par value $0.01

    (indirect: See Footnote)
    Common Stock (131,697 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (23,733 underlying)
  • Series A Preferred Stock Warrant (right to buy)

    (indirect: See Footnote)
    Exercise: $5.45Common Stock (15,804 underlying)
Footnotes (8)
  • [F1]These securities are directly held by Health Wildcatters Fund II, LLC ("HWF II"). Carl D. Soderstrom and Clay M. Heighten, M.D. are the managing members of Green Park & Golf Ventures, LLC ("GPG"), which is the managing member of Health Wildcatters, LLC ("HW"), which is the managing member of HWF II. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., GPG, and HW may be deemed to beneficially own these securities.
  • [F2]The Reporting Person acquired these shares of the Issuer's Common Stock, par value $0.0001 (the "Common Stock"), in connection with a series of private transactions conducted prior to the Issuer's initial public offering which commenced on June 10, 2020 (the "Initial Public Offering"). The number of shares of Common Stock set forth in Table I gives effect to the Stock Split (as defined below), which resulted in HWF II's beneficial ownership of Common Stock increasing from 97,561 shares to 169,756 shares.
  • [F3]The number of underlying shares of Common Stock reported in Column 3 of Table II reflects and gives effect to a 1.74-for-1 stock split (the "Stock Split"), to be made effective immediately prior to the closing of the Initial Public Offering.
  • [F4]The Issuer's Series A Preferred Stock, par value $0.01 (the "Series A Preferred Stock"), is convertible at any time, at the holder's election, on a one-for-one basis (subject to adjustments for anti-dilution) for Common Stock, and has no expiration date. In addition, the Series A Preferred Stock will automatically convert into Common Stock upon the closing of an initial public offering meeting certain specified conditions, and it will also convert into Common Stock in the event holders of at least 75% of the Series A Preferred Stock approve a mandatory conversion.
  • [F5]These securities are directly held by GPG LPI Investment, LLC ("GPG LPI"). Carl D. Soderstrom and Clay M. Heighten, M.D. are the managing members of GPG, which is the managing member GPG LPI. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., and GPG may be deemed to beneficially own these securities.
  • [F6]These securities are directly held by Lantern 3-19 Investment, LLC ("Lantern 3-19"). Carl D. Soderstrom, Clay M. Heighten, M.D., and Gilbert G. Garcia II are the managing members of Green Park & Golf Ventures II, LLC ("GPG II"), which is the managing member Lantern 3-19. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., Gilbert G. Garcia II, and GPG II may be deemed to beneficially own these securities.
  • [F7]The Series A Preferred Stock Warrant is exercisable at any time, at the holder's election, up to and until the Expiration Date (as defined below).
  • [F8]Each Series A Preferred Stock Warrant will expire and no longer be exercisable upon the earliest to occur of (a) 5:00 PM (pacific time) on the fifth anniversary of the date of issuance of such Series A Preferred Stock Warrant and (b) the consummation of a Change of Control (as such term is set forth in the Form of Preferred Stock Warrant filed with the SEC on April 16, 2020, as subsequently amended by that certain Form of Amendment to Preferred Stock Warrant filed with the SEC on May 19, 2020) (collectively, the "Expiration Date").

Issuer

Lantern Pharma Inc.

CIK 0001763950

Entity typeother
IncorporatedTX

Related Parties

1
  • filerCIK 0001782733

Filing Metadata

Form type
3
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 6:50 PM ET
Size
26.5 KB